Profile
Carlos Camara was the founder of Tribogenics, Inc. which was founded in 2011, where he held the title of Chief Scientist.
He is currently the Chief Executive Officer at Metagreen.
Dr. Camara's former job was as a Research Associate at the University of California, Los Angeles from 2010 to 2011.
Dr. Camara earned his doctorate degree from the University of California, Los Angeles in 2006 and his undergraduate degree from Universidad Nacional Autónoma de México in 1998.
Carlos Camara active positions
| Companies | Position | Start |
|---|---|---|
Metagreen
Metagreen Pharmaceuticals: OtherHealth Technology Develops hemp products | Chief Executive Officer | - |
Former positions of Carlos Camara
| Companies | Position | End |
|---|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2011-05-31 |
Tribogenics, Inc.
Tribogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Manufactures XRF technology for metal alloy identification | Founder | - |
Training of Carlos Camara
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Tribogenics, Inc.
Tribogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Manufactures XRF technology for metal alloy identification | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Nacional Autónoma de México
Universidad Nacional Autónoma de México Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metagreen
Metagreen Pharmaceuticals: OtherHealth Technology Develops hemp products | Health Technology |
- Stock Market
- Insiders
- Carlos Camara
















